| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delivery of Health Care, Integrated | 16 | 2023 | 290 | 3.720 |
Why?
|
| Hypertension | 17 | 2023 | 1251 | 2.960 |
Why?
|
| Diabetes Mellitus | 20 | 2022 | 1072 | 2.790 |
Why?
|
| Medication Adherence | 13 | 2022 | 510 | 2.700 |
Why?
|
| Drug Monitoring | 10 | 2024 | 398 | 2.220 |
Why?
|
| Primary Health Care | 24 | 2022 | 1756 | 2.070 |
Why?
|
| Ambulatory Care Facilities | 7 | 2021 | 246 | 2.060 |
Why?
|
| Appointments and Schedules | 7 | 2023 | 96 | 2.010 |
Why?
|
| Text Messaging | 4 | 2023 | 179 | 1.900 |
Why?
|
| Delivery of Health Care | 13 | 2023 | 949 | 1.770 |
Why?
|
| Antihypertensive Agents | 10 | 2023 | 507 | 1.730 |
Why?
|
| Food Supply | 4 | 2018 | 90 | 1.680 |
Why?
|
| Hypoglycemic Agents | 11 | 2017 | 1368 | 1.670 |
Why?
|
| Patient Compliance | 8 | 2023 | 607 | 1.470 |
Why?
|
| Reminder Systems | 5 | 2021 | 174 | 1.460 |
Why?
|
| Telephone | 6 | 2021 | 180 | 1.440 |
Why?
|
| Colorado | 50 | 2026 | 4597 | 1.370 |
Why?
|
| Humans | 197 | 2026 | 140898 | 1.290 |
Why?
|
| Socioeconomic Factors | 23 | 2020 | 1310 | 1.200 |
Why?
|
| Ambulatory Care | 8 | 2024 | 584 | 1.140 |
Why?
|
| Aged | 73 | 2023 | 24666 | 1.110 |
Why?
|
| Male | 124 | 2026 | 69893 | 1.070 |
Why?
|
| Health Maintenance Organizations | 9 | 2018 | 105 | 1.060 |
Why?
|
| Electronic Health Records | 10 | 2024 | 1125 | 1.050 |
Why?
|
| Female | 122 | 2026 | 75540 | 1.040 |
Why?
|
| Patient-Centered Care | 8 | 2023 | 536 | 1.030 |
Why?
|
| Hospitalization | 12 | 2023 | 2261 | 0.980 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2022 | 876 | 0.980 |
Why?
|
| United States | 59 | 2025 | 15195 | 0.970 |
Why?
|
| Mentors | 4 | 2015 | 212 | 0.970 |
Why?
|
| Mass Screening | 8 | 2022 | 1300 | 0.960 |
Why?
|
| Middle Aged | 76 | 2026 | 34487 | 0.940 |
Why?
|
| Retrospective Studies | 40 | 2023 | 16315 | 0.910 |
Why?
|
| Health Status | 10 | 2022 | 820 | 0.890 |
Why?
|
| Narration | 4 | 2016 | 68 | 0.880 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2020 | 2524 | 0.880 |
Why?
|
| Chronic Disease | 16 | 2019 | 1811 | 0.870 |
Why?
|
| Practice Patterns, Physicians' | 10 | 2024 | 1328 | 0.860 |
Why?
|
| Child Health Services | 8 | 2009 | 196 | 0.830 |
Why?
|
| Blood Pressure | 10 | 2023 | 1745 | 0.800 |
Why?
|
| Research | 6 | 2012 | 431 | 0.800 |
Why?
|
| Community-Institutional Relations | 3 | 2009 | 102 | 0.790 |
Why?
|
| Health Insurance Exchanges | 1 | 2022 | 2 | 0.780 |
Why?
|
| Comorbidity | 14 | 2015 | 1658 | 0.780 |
Why?
|
| Cohort Studies | 28 | 2021 | 5789 | 0.770 |
Why?
|
| Comparative Effectiveness Research | 2 | 2015 | 164 | 0.760 |
Why?
|
| Health Services Needs and Demand | 6 | 2019 | 282 | 0.750 |
Why?
|
| Communication | 5 | 2023 | 948 | 0.740 |
Why?
|
| Adult | 64 | 2026 | 39134 | 0.740 |
Why?
|
| Social Determinants of Health | 3 | 2025 | 273 | 0.740 |
Why?
|
| Biomedical Research | 4 | 2014 | 680 | 0.730 |
Why?
|
| Vulnerable Populations | 6 | 2022 | 170 | 0.720 |
Why?
|
| Loneliness | 1 | 2022 | 54 | 0.720 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 2082 | 0.720 |
Why?
|
| Proportional Hazards Models | 9 | 2021 | 1261 | 0.720 |
Why?
|
| Quality Assurance, Health Care | 6 | 2012 | 318 | 0.710 |
Why?
|
| Health Services Research | 7 | 2019 | 402 | 0.700 |
Why?
|
| Hyperlipidemias | 3 | 2012 | 125 | 0.700 |
Why?
|
| Sociological Factors | 1 | 2021 | 6 | 0.690 |
Why?
|
| Risk Factors | 28 | 2022 | 10430 | 0.690 |
Why?
|
| State Health Plans | 4 | 2005 | 33 | 0.680 |
Why?
|
| Survivors | 4 | 2010 | 501 | 0.680 |
Why?
|
| Activities of Daily Living | 3 | 2023 | 425 | 0.670 |
Why?
|
| Preventive Health Services | 4 | 2007 | 154 | 0.660 |
Why?
|
| Patient Participation | 2 | 2015 | 424 | 0.650 |
Why?
|
| Hypokalemia | 1 | 2020 | 24 | 0.640 |
Why?
|
| Immunization | 6 | 2009 | 405 | 0.640 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2020 | 17 | 0.640 |
Why?
|
| Prostatic Neoplasms | 7 | 2014 | 1046 | 0.630 |
Why?
|
| Quality of Life | 10 | 2019 | 3005 | 0.630 |
Why?
|
| Urban Population | 7 | 2021 | 481 | 0.630 |
Why?
|
| Hyperkalemia | 1 | 2020 | 28 | 0.630 |
Why?
|
| Renal Dialysis | 6 | 2026 | 457 | 0.600 |
Why?
|
| Medical Order Entry Systems | 1 | 2019 | 44 | 0.590 |
Why?
|
| Patient Satisfaction | 10 | 2019 | 690 | 0.590 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2019 | 34 | 0.580 |
Why?
|
| Continuity of Patient Care | 4 | 2017 | 284 | 0.580 |
Why?
|
| Social Work | 1 | 2019 | 85 | 0.570 |
Why?
|
| Depression | 5 | 2022 | 1487 | 0.570 |
Why?
|
| Kidney Failure, Chronic | 5 | 2026 | 599 | 0.570 |
Why?
|
| Health Services Accessibility | 9 | 2021 | 1020 | 0.570 |
Why?
|
| Ecosystem | 1 | 2023 | 576 | 0.570 |
Why?
|
| Needs Assessment | 2 | 2019 | 384 | 0.570 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2015 | 449 | 0.560 |
Why?
|
| Racism | 3 | 2021 | 139 | 0.560 |
Why?
|
| Drug Prescriptions | 3 | 2009 | 263 | 0.560 |
Why?
|
| Health Services | 2 | 2012 | 115 | 0.550 |
Why?
|
| Health Behavior | 8 | 2014 | 783 | 0.550 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2008 | 119 | 0.540 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 193 | 0.540 |
Why?
|
| Office Visits | 4 | 2007 | 95 | 0.540 |
Why?
|
| Physician-Patient Relations | 7 | 2017 | 580 | 0.540 |
Why?
|
| Internal Medicine | 6 | 2008 | 273 | 0.530 |
Why?
|
| Father-Child Relations | 1 | 2017 | 8 | 0.530 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 100 | 0.530 |
Why?
|
| Self Administration | 2 | 2016 | 126 | 0.530 |
Why?
|
| Prisons | 3 | 2014 | 82 | 0.530 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2018 | 197 | 0.520 |
Why?
|
| Research Personnel | 2 | 2016 | 177 | 0.520 |
Why?
|
| Diabetes Complications | 2 | 2018 | 222 | 0.510 |
Why?
|
| Employment | 3 | 2008 | 179 | 0.500 |
Why?
|
| Patient Discharge | 1 | 2023 | 930 | 0.500 |
Why?
|
| Games, Recreational | 1 | 2016 | 3 | 0.490 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 2190 | 0.480 |
Why?
|
| Metformin | 2 | 2017 | 329 | 0.480 |
Why?
|
| Surveys and Questionnaires | 19 | 2023 | 5931 | 0.480 |
Why?
|
| Insurance, Health | 6 | 2022 | 298 | 0.470 |
Why?
|
| Prisoners | 3 | 2014 | 142 | 0.460 |
Why?
|
| Neoplasms | 7 | 2014 | 2718 | 0.460 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 263 | 0.460 |
Why?
|
| Referral and Consultation | 4 | 2018 | 794 | 0.460 |
Why?
|
| Physicians | 4 | 2022 | 928 | 0.450 |
Why?
|
| Community Health Centers | 3 | 2012 | 63 | 0.450 |
Why?
|
| Sickness Impact Profile | 2 | 2005 | 58 | 0.450 |
Why?
|
| Cholesterol, LDL | 6 | 2016 | 360 | 0.450 |
Why?
|
| Problem Solving | 1 | 2016 | 156 | 0.440 |
Why?
|
| Kidney | 4 | 2022 | 1475 | 0.440 |
Why?
|
| Attitude to Health | 4 | 2021 | 451 | 0.440 |
Why?
|
| Medically Uninsured | 4 | 2007 | 136 | 0.440 |
Why?
|
| Adolescent | 26 | 2025 | 22027 | 0.430 |
Why?
|
| Aged, 80 and over | 21 | 2021 | 7899 | 0.430 |
Why?
|
| Competency-Based Education | 1 | 2015 | 75 | 0.430 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 455 | 0.430 |
Why?
|
| Professional Competence | 1 | 2015 | 97 | 0.430 |
Why?
|
| Self Report | 5 | 2022 | 858 | 0.430 |
Why?
|
| Internet | 6 | 2016 | 682 | 0.430 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 32 | 0.420 |
Why?
|
| Databases as Topic | 1 | 2014 | 68 | 0.420 |
Why?
|
| Attitude of Health Personnel | 6 | 2012 | 1175 | 0.420 |
Why?
|
| Medical Assistance | 2 | 2022 | 15 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 1856 | 0.410 |
Why?
|
| Health Care Surveys | 9 | 2013 | 562 | 0.410 |
Why?
|
| Age Factors | 12 | 2022 | 3278 | 0.410 |
Why?
|
| Health Education | 3 | 2019 | 360 | 0.410 |
Why?
|
| Follow-Up Studies | 11 | 2022 | 5194 | 0.410 |
Why?
|
| Hyperglycemia | 1 | 2017 | 363 | 0.400 |
Why?
|
| Risk Assessment | 9 | 2015 | 3484 | 0.390 |
Why?
|
| Counseling | 2 | 2014 | 395 | 0.390 |
Why?
|
| Family Practice | 5 | 2008 | 440 | 0.390 |
Why?
|
| Prescription Drugs | 1 | 2014 | 112 | 0.380 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 285 | 0.380 |
Why?
|
| Education, Medical, Continuing | 2 | 2025 | 128 | 0.380 |
Why?
|
| Treatment Refusal | 3 | 2007 | 96 | 0.370 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 1125 | 0.370 |
Why?
|
| Overweight | 3 | 2022 | 587 | 0.370 |
Why?
|
| International Classification of Diseases | 2 | 2015 | 138 | 0.370 |
Why?
|
| Managed Care Programs | 6 | 2017 | 140 | 0.370 |
Why?
|
| Morbidity | 2 | 2015 | 320 | 0.370 |
Why?
|
| Medicare Part C | 1 | 2012 | 31 | 0.370 |
Why?
|
| Prostatectomy | 3 | 2006 | 102 | 0.360 |
Why?
|
| Health Status Disparities | 4 | 2022 | 297 | 0.360 |
Why?
|
| Life Style | 1 | 2014 | 478 | 0.360 |
Why?
|
| Pharmaceutical Services | 2 | 2013 | 83 | 0.350 |
Why?
|
| Alaska Natives | 2 | 2025 | 154 | 0.350 |
Why?
|
| Terminology as Topic | 1 | 2013 | 244 | 0.350 |
Why?
|
| Quality of Health Care | 7 | 2021 | 645 | 0.350 |
Why?
|
| Faculty, Medical | 2 | 2014 | 292 | 0.350 |
Why?
|
| Young Adult | 18 | 2025 | 13646 | 0.350 |
Why?
|
| Case Management | 2 | 2009 | 66 | 0.350 |
Why?
|
| Social Adjustment | 1 | 2011 | 64 | 0.340 |
Why?
|
| Odds Ratio | 6 | 2021 | 1054 | 0.340 |
Why?
|
| Infant | 20 | 2024 | 9790 | 0.340 |
Why?
|
| Insulin | 3 | 2017 | 2458 | 0.340 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 92 | 0.340 |
Why?
|
| Pneumococcal Vaccines | 3 | 2008 | 138 | 0.340 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 153 | 0.330 |
Why?
|
| Colonoscopy | 4 | 2023 | 250 | 0.330 |
Why?
|
| Undocumented Immigrants | 2 | 2023 | 55 | 0.330 |
Why?
|
| Registries | 10 | 2015 | 2143 | 0.330 |
Why?
|
| Kidney Diseases | 2 | 2011 | 408 | 0.330 |
Why?
|
| Workplace | 2 | 2010 | 264 | 0.320 |
Why?
|
| Healthcare Disparities | 6 | 2022 | 671 | 0.320 |
Why?
|
| Patient Navigation | 3 | 2026 | 98 | 0.320 |
Why?
|
| Social Support | 4 | 2019 | 629 | 0.320 |
Why?
|
| Cross-Sectional Studies | 17 | 2022 | 5645 | 0.320 |
Why?
|
| Self Care | 4 | 2008 | 392 | 0.310 |
Why?
|
| Bell Palsy | 1 | 2009 | 9 | 0.310 |
Why?
|
| Osteoarthritis | 3 | 2008 | 203 | 0.310 |
Why?
|
| Minority Groups | 3 | 2022 | 277 | 0.310 |
Why?
|
| Heart Failure | 7 | 2015 | 2093 | 0.310 |
Why?
|
| Models, Biological | 1 | 2017 | 1822 | 0.310 |
Why?
|
| Isosorbide Dinitrate | 1 | 2009 | 3 | 0.300 |
Why?
|
| Clinical Competence | 4 | 2014 | 1196 | 0.300 |
Why?
|
| Hydralazine | 1 | 2009 | 6 | 0.300 |
Why?
|
| Urban Health | 2 | 2006 | 95 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 1536 | 0.300 |
Why?
|
| Multivariate Analysis | 11 | 2014 | 1496 | 0.300 |
Why?
|
| Fellowships and Scholarships | 3 | 2003 | 323 | 0.300 |
Why?
|
| Health Status Indicators | 2 | 2014 | 161 | 0.300 |
Why?
|
| Depressive Disorder | 2 | 2011 | 374 | 0.300 |
Why?
|
| Time Factors | 12 | 2015 | 6944 | 0.300 |
Why?
|
| Insurance Coverage | 3 | 2007 | 239 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2760 | 0.290 |
Why?
|
| Health Policy | 3 | 2007 | 380 | 0.280 |
Why?
|
| Child, Preschool | 18 | 2024 | 11462 | 0.280 |
Why?
|
| Population Surveillance | 5 | 2019 | 479 | 0.280 |
Why?
|
| Prevalence | 10 | 2025 | 2780 | 0.280 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2012 | 711 | 0.280 |
Why?
|
| Interprofessional Relations | 3 | 2014 | 282 | 0.280 |
Why?
|
| Electrocardiography | 2 | 2008 | 617 | 0.280 |
Why?
|
| Immunization Programs | 4 | 2007 | 221 | 0.280 |
Why?
|
| Vaccination | 3 | 2022 | 1467 | 0.280 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 265 | 0.280 |
Why?
|
| Indians, North American | 2 | 2025 | 655 | 0.280 |
Why?
|
| Quality Improvement | 4 | 2025 | 1234 | 0.270 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2552 | 0.270 |
Why?
|
| Social Values | 2 | 2021 | 39 | 0.270 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2007 | 24 | 0.270 |
Why?
|
| Physician Impairment | 1 | 2007 | 15 | 0.270 |
Why?
|
| Survival Analysis | 2 | 2008 | 1320 | 0.270 |
Why?
|
| Drug Overdose | 1 | 2012 | 356 | 0.270 |
Why?
|
| Hypoglycemia | 3 | 2017 | 467 | 0.270 |
Why?
|
| Models, Statistical | 3 | 2014 | 667 | 0.260 |
Why?
|
| Drug Therapy, Combination | 3 | 2018 | 1038 | 0.260 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 330 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3724 | 0.260 |
Why?
|
| Information Dissemination | 2 | 2016 | 209 | 0.260 |
Why?
|
| Child Care | 1 | 2007 | 33 | 0.260 |
Why?
|
| Health Surveys | 5 | 2015 | 511 | 0.250 |
Why?
|
| After-Hours Care | 1 | 2006 | 17 | 0.250 |
Why?
|
| Medicare | 4 | 2018 | 806 | 0.250 |
Why?
|
| Blood Glucose | 4 | 2015 | 2273 | 0.250 |
Why?
|
| Hospitals, University | 2 | 2008 | 175 | 0.250 |
Why?
|
| Triage | 2 | 2006 | 246 | 0.250 |
Why?
|
| Policy Making | 2 | 2005 | 79 | 0.240 |
Why?
|
| Community Health Services | 2 | 2008 | 232 | 0.240 |
Why?
|
| Linear Models | 5 | 2011 | 854 | 0.240 |
Why?
|
| Qualitative Research | 7 | 2021 | 1525 | 0.240 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 501 | 0.240 |
Why?
|
| Urology | 1 | 2006 | 61 | 0.240 |
Why?
|
| Dyslipidemias | 1 | 2007 | 175 | 0.240 |
Why?
|
| Clinical Medicine | 1 | 2005 | 25 | 0.240 |
Why?
|
| Education, Continuing | 1 | 2025 | 41 | 0.230 |
Why?
|
| Emergencies | 1 | 2006 | 179 | 0.230 |
Why?
|
| Value of Life | 1 | 2005 | 19 | 0.230 |
Why?
|
| Marital Status | 1 | 2005 | 46 | 0.230 |
Why?
|
| Staff Development | 1 | 2025 | 60 | 0.220 |
Why?
|
| Community Health Workers | 1 | 2026 | 76 | 0.220 |
Why?
|
| Health Promotion | 2 | 2009 | 748 | 0.220 |
Why?
|
| Work | 1 | 2004 | 23 | 0.220 |
Why?
|
| Bone Density | 1 | 2009 | 495 | 0.220 |
Why?
|
| Anxiety | 3 | 2022 | 1076 | 0.220 |
Why?
|
| Incidence | 7 | 2015 | 2782 | 0.220 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 318 | 0.220 |
Why?
|
| Weight Gain | 2 | 2026 | 537 | 0.220 |
Why?
|
| Carcinoma | 1 | 2006 | 230 | 0.220 |
Why?
|
| Foot Diseases | 1 | 2004 | 18 | 0.220 |
Why?
|
| Foot Deformities | 1 | 2004 | 11 | 0.220 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 2898 | 0.210 |
Why?
|
| Interrupted Time Series Analysis | 2 | 2024 | 72 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 4 | 2018 | 752 | 0.210 |
Why?
|
| Insurance Claim Review | 3 | 2015 | 85 | 0.200 |
Why?
|
| Substance-Related Disorders | 2 | 2012 | 1093 | 0.200 |
Why?
|
| Interviews as Topic | 6 | 2011 | 841 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2009 | 746 | 0.200 |
Why?
|
| Program Evaluation | 5 | 2023 | 919 | 0.200 |
Why?
|
| Career Choice | 2 | 2003 | 232 | 0.200 |
Why?
|
| Poverty | 5 | 2025 | 527 | 0.200 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 805 | 0.200 |
Why?
|
| Child, Hospitalized | 1 | 2003 | 53 | 0.200 |
Why?
|
| Child | 16 | 2024 | 22313 | 0.200 |
Why?
|
| Medical Staff | 1 | 2002 | 17 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2017 | 3788 | 0.190 |
Why?
|
| Patient Readmission | 2 | 2023 | 707 | 0.190 |
Why?
|
| Hospitals, Pediatric | 1 | 2006 | 532 | 0.190 |
Why?
|
| Physician's Role | 1 | 2004 | 217 | 0.190 |
Why?
|
| Egg Hypersensitivity | 1 | 2022 | 32 | 0.190 |
Why?
|
| Medical Records Systems, Computerized | 3 | 2008 | 96 | 0.190 |
Why?
|
| Compassion Fatigue | 1 | 2022 | 31 | 0.190 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 521 | 0.190 |
Why?
|
| Training Support | 1 | 2002 | 36 | 0.190 |
Why?
|
| Phobic Disorders | 1 | 2022 | 36 | 0.180 |
Why?
|
| Health Facilities | 1 | 2022 | 82 | 0.180 |
Why?
|
| Eczema | 1 | 2022 | 70 | 0.180 |
Why?
|
| Health Fairs | 1 | 2002 | 10 | 0.180 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 176 | 0.180 |
Why?
|
| Demography | 4 | 2008 | 295 | 0.180 |
Why?
|
| Disease Management | 4 | 2015 | 628 | 0.180 |
Why?
|
| Behavior Therapy | 1 | 2004 | 282 | 0.180 |
Why?
|
| Meals | 1 | 2023 | 132 | 0.180 |
Why?
|
| Awards and Prizes | 1 | 2002 | 72 | 0.170 |
Why?
|
| Acculturation | 2 | 2012 | 53 | 0.170 |
Why?
|
| Infant, Newborn | 7 | 2009 | 6257 | 0.170 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 169 | 0.170 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 772 | 0.170 |
Why?
|
| Data Collection | 5 | 2012 | 651 | 0.170 |
Why?
|
| New Mexico | 1 | 2021 | 101 | 0.170 |
Why?
|
| Complementary Therapies | 1 | 2002 | 90 | 0.170 |
Why?
|
| Peanut Hypersensitivity | 1 | 2022 | 147 | 0.170 |
Why?
|
| Culturally Competent Care | 1 | 2021 | 68 | 0.170 |
Why?
|
| Prognosis | 5 | 2017 | 4060 | 0.160 |
Why?
|
| Regression Analysis | 5 | 2007 | 1015 | 0.160 |
Why?
|
| Pyelonephritis | 1 | 2020 | 11 | 0.160 |
Why?
|
| Body Mass Index | 3 | 2025 | 2374 | 0.160 |
Why?
|
| Communication Barriers | 1 | 2021 | 115 | 0.160 |
Why?
|
| Cystitis | 1 | 2020 | 23 | 0.160 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 83 | 0.160 |
Why?
|
| Cephalexin | 1 | 2020 | 14 | 0.160 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 42 | 0.160 |
Why?
|
| Electronic Mail | 2 | 2013 | 65 | 0.160 |
Why?
|
| Transportation | 1 | 2020 | 52 | 0.160 |
Why?
|
| Geography | 1 | 2020 | 199 | 0.160 |
Why?
|
| Potassium | 1 | 2020 | 148 | 0.150 |
Why?
|
| Information Services | 1 | 2019 | 45 | 0.150 |
Why?
|
| Internship and Residency | 4 | 2006 | 1222 | 0.150 |
Why?
|
| Obesity | 3 | 2025 | 3000 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 373 | 0.150 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 273 | 0.150 |
Why?
|
| Patient Selection | 3 | 2009 | 684 | 0.150 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 2920 | 0.140 |
Why?
|
| Smoking | 3 | 2015 | 1573 | 0.140 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2018 | 9 | 0.140 |
Why?
|
| Contraception Behavior | 1 | 2019 | 101 | 0.140 |
Why?
|
| Wounds and Injuries | 2 | 2006 | 896 | 0.140 |
Why?
|
| Pneumonia | 1 | 2024 | 656 | 0.140 |
Why?
|
| Secondary Prevention | 2 | 2017 | 240 | 0.140 |
Why?
|
| Cluster Analysis | 3 | 2011 | 516 | 0.140 |
Why?
|
| Logistic Models | 4 | 2012 | 2088 | 0.140 |
Why?
|
| Nomograms | 2 | 2014 | 58 | 0.130 |
Why?
|
| Northwestern United States | 1 | 2017 | 57 | 0.130 |
Why?
|
| Pandemics | 2 | 2023 | 1643 | 0.130 |
Why?
|
| Probability | 3 | 2010 | 308 | 0.130 |
Why?
|
| Patients | 2 | 2011 | 179 | 0.130 |
Why?
|
| Prospective Studies | 6 | 2023 | 7749 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 1396 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 171 | 0.130 |
Why?
|
| Critical Care | 1 | 2022 | 650 | 0.130 |
Why?
|
| Peer Group | 1 | 2019 | 247 | 0.130 |
Why?
|
| Organizational Case Studies | 2 | 2025 | 74 | 0.130 |
Why?
|
| Epidemiological Monitoring | 2 | 2015 | 65 | 0.130 |
Why?
|
| Learning | 1 | 2021 | 434 | 0.130 |
Why?
|
| Attitude to Death | 1 | 2017 | 69 | 0.130 |
Why?
|
| Malnutrition | 1 | 2018 | 84 | 0.130 |
Why?
|
| Minnesota | 1 | 2017 | 168 | 0.130 |
Why?
|
| Blood Pressure Determination | 2 | 2015 | 145 | 0.120 |
Why?
|
| Utilization Review | 2 | 2009 | 41 | 0.120 |
Why?
|
| Mental Disorders | 2 | 2008 | 1123 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1395 | 0.120 |
Why?
|
| Physicians, Family | 2 | 2008 | 192 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2022 | 458 | 0.120 |
Why?
|
| Information Seeking Behavior | 1 | 2016 | 37 | 0.120 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 599 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2007 | 2813 | 0.110 |
Why?
|
| Asthma | 2 | 2022 | 1919 | 0.110 |
Why?
|
| Total Quality Management | 2 | 2007 | 59 | 0.110 |
Why?
|
| Survival Rate | 4 | 2015 | 1962 | 0.110 |
Why?
|
| House Calls | 2 | 2009 | 144 | 0.110 |
Why?
|
| Arizona | 1 | 2014 | 81 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2017 | 367 | 0.110 |
Why?
|
| Cost Sharing | 2 | 2015 | 19 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 2062 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 110 | 0.110 |
Why?
|
| Organizational Policy | 1 | 2014 | 76 | 0.110 |
Why?
|
| Computer Security | 1 | 2014 | 24 | 0.110 |
Why?
|
| Exercise | 3 | 2021 | 2108 | 0.100 |
Why?
|
| Privacy | 1 | 2014 | 39 | 0.100 |
Why?
|
| SEER Program | 3 | 2014 | 219 | 0.100 |
Why?
|
| Family | 3 | 2020 | 677 | 0.100 |
Why?
|
| Confidentiality | 1 | 2014 | 72 | 0.100 |
Why?
|
| Organizational Innovation | 1 | 2014 | 128 | 0.100 |
Why?
|
| Sulfonylurea Compounds | 1 | 2013 | 49 | 0.100 |
Why?
|
| Disease Progression | 2 | 2011 | 2791 | 0.100 |
Why?
|
| Eligibility Determination | 2 | 2004 | 68 | 0.100 |
Why?
|
| Decision Making | 3 | 2006 | 950 | 0.100 |
Why?
|
| Patient Access to Records | 1 | 2013 | 19 | 0.100 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 250 | 0.100 |
Why?
|
| Stereotyped Behavior | 1 | 2012 | 23 | 0.100 |
Why?
|
| Social Media | 1 | 2016 | 159 | 0.100 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 437 | 0.100 |
Why?
|
| Telemedicine | 1 | 2022 | 886 | 0.100 |
Why?
|
| Anti-HIV Agents | 2 | 2011 | 846 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2014 | 99 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2016 | 580 | 0.100 |
Why?
|
| Influenza Vaccines | 2 | 2008 | 551 | 0.090 |
Why?
|
| User-Computer Interface | 2 | 2012 | 163 | 0.090 |
Why?
|
| Reimbursement, Incentive | 1 | 2012 | 41 | 0.090 |
Why?
|
| Parents | 3 | 2006 | 1440 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2013 | 59 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2011 | 278 | 0.090 |
Why?
|
| Medicaid | 2 | 2009 | 446 | 0.090 |
Why?
|
| Program Development | 2 | 2019 | 364 | 0.090 |
Why?
|
| Risk | 2 | 2022 | 903 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 362 | 0.090 |
Why?
|
| Teaching | 2 | 2006 | 233 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 399 | 0.090 |
Why?
|
| Nurses | 2 | 2006 | 182 | 0.090 |
Why?
|
| Pharmacists | 1 | 2014 | 255 | 0.090 |
Why?
|
| Pediatrics | 3 | 2006 | 1097 | 0.090 |
Why?
|
| Medical Record Linkage | 1 | 2012 | 68 | 0.090 |
Why?
|
| Cultural Competency | 2 | 2013 | 94 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 2015 | 293 | 0.090 |
Why?
|
| Forensic Psychiatry | 1 | 2011 | 29 | 0.090 |
Why?
|
| HIV Infections | 3 | 2011 | 2967 | 0.090 |
Why?
|
| Urban Health Services | 2 | 2009 | 68 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2012 | 99 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 527 | 0.090 |
Why?
|
| Pregnancy | 3 | 2022 | 7035 | 0.080 |
Why?
|
| Primary Prevention | 2 | 2013 | 201 | 0.080 |
Why?
|
| Birth Weight | 2 | 2022 | 511 | 0.080 |
Why?
|
| Audiovisual Aids | 1 | 2009 | 12 | 0.080 |
Why?
|
| Medicare Part D | 1 | 2010 | 25 | 0.080 |
Why?
|
| Outpatients | 2 | 2024 | 418 | 0.080 |
Why?
|
| Physicians, Primary Care | 1 | 2013 | 225 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 68 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2012 | 11125 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 622 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2011 | 341 | 0.070 |
Why?
|
| Self Disclosure | 1 | 2008 | 65 | 0.070 |
Why?
|
| Drug Resistance, Viral | 1 | 2009 | 120 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2014 | 785 | 0.070 |
Why?
|
| Mental Health Services | 2 | 2004 | 445 | 0.070 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2008 | 40 | 0.070 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 47 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 73 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2009 | 365 | 0.070 |
Why?
|
| Safety | 2 | 2007 | 356 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2013 | 1441 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 99 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 1031 | 0.070 |
Why?
|
| Sex Factors | 4 | 2020 | 2051 | 0.070 |
Why?
|
| Psychology | 1 | 2008 | 89 | 0.070 |
Why?
|
| Geriatrics | 1 | 2008 | 93 | 0.070 |
Why?
|
| Curriculum | 1 | 2014 | 1029 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2008 | 298 | 0.060 |
Why?
|
| Correspondence as Topic | 1 | 2007 | 16 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 280 | 0.060 |
Why?
|
| Pamphlets | 1 | 2006 | 26 | 0.060 |
Why?
|
| Anecdotes as Topic | 1 | 2006 | 7 | 0.060 |
Why?
|
| Accident Prevention | 1 | 2006 | 25 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 32 | 0.060 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 39 | 0.060 |
Why?
|
| Attitude | 2 | 2005 | 257 | 0.060 |
Why?
|
| Culture | 1 | 2007 | 129 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 381 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 2006 | 66 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2007 | 143 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2008 | 310 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2009 | 242 | 0.060 |
Why?
|
| Patient Dropouts | 1 | 2006 | 65 | 0.060 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2008 | 160 | 0.060 |
Why?
|
| Cholesterol | 1 | 2007 | 404 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 81 | 0.060 |
Why?
|
| Postal Service | 3 | 2015 | 30 | 0.060 |
Why?
|
| Mental Health | 1 | 2012 | 753 | 0.060 |
Why?
|
| Alcoholism | 1 | 2012 | 821 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2005 | 122 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1313 | 0.060 |
Why?
|
| Chicago | 1 | 2004 | 61 | 0.050 |
Why?
|
| Los Angeles | 1 | 2004 | 75 | 0.050 |
Why?
|
| Suicide | 1 | 2012 | 669 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 678 | 0.050 |
Why?
|
| Boston | 1 | 2004 | 91 | 0.050 |
Why?
|
| Podiatry | 1 | 2004 | 5 | 0.050 |
Why?
|
| Drug Costs | 1 | 2005 | 114 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2008 | 1598 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 270 | 0.050 |
Why?
|
| Age Distribution | 1 | 2005 | 397 | 0.050 |
Why?
|
| Algorithms | 2 | 2011 | 1763 | 0.050 |
Why?
|
| Educational Status | 1 | 2006 | 462 | 0.050 |
Why?
|
| Fee-for-Service Plans | 1 | 2004 | 88 | 0.050 |
Why?
|
| Brachytherapy | 1 | 2005 | 131 | 0.050 |
Why?
|
| Herpes Zoster | 1 | 2008 | 319 | 0.050 |
Why?
|
| Happiness | 1 | 2004 | 24 | 0.050 |
Why?
|
| Goals | 1 | 2005 | 178 | 0.050 |
Why?
|
| Mortality | 1 | 2006 | 359 | 0.050 |
Why?
|
| United Kingdom | 1 | 2005 | 319 | 0.050 |
Why?
|
| Public Health Practice | 1 | 2004 | 67 | 0.050 |
Why?
|
| Social Class | 1 | 2005 | 268 | 0.050 |
Why?
|
| Specialization | 1 | 2004 | 130 | 0.050 |
Why?
|
| Self Concept | 1 | 2005 | 259 | 0.050 |
Why?
|
| Echinacea | 1 | 2003 | 2 | 0.050 |
Why?
|
| Medical Indigency | 1 | 2003 | 12 | 0.050 |
Why?
|
| Public Health Informatics | 1 | 2003 | 9 | 0.050 |
Why?
|
| Self-Help Groups | 1 | 2023 | 37 | 0.050 |
Why?
|
| HIV-1 | 1 | 2009 | 880 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2004 | 151 | 0.050 |
Why?
|
| Drug Labeling | 1 | 2003 | 38 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 137 | 0.050 |
Why?
|
| Herpes Genitalis | 1 | 2002 | 18 | 0.050 |
Why?
|
| Truth Disclosure | 1 | 2003 | 46 | 0.050 |
Why?
|
| Professional Autonomy | 1 | 2002 | 31 | 0.050 |
Why?
|
| Home Care Agencies | 1 | 2002 | 7 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 28 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 1048 | 0.050 |
Why?
|
| Medicine | 1 | 2004 | 125 | 0.050 |
Why?
|
| Hotlines | 1 | 2002 | 36 | 0.050 |
Why?
|
| Financing, Personal | 1 | 2002 | 28 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2022 | 63 | 0.050 |
Why?
|
| Antimicrobial Stewardship | 1 | 2024 | 119 | 0.050 |
Why?
|
| Drug Utilization | 2 | 2015 | 166 | 0.050 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 76 | 0.050 |
Why?
|
| Arachis | 1 | 2022 | 112 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2002 | 145 | 0.040 |
Why?
|
| Publishing | 1 | 2002 | 109 | 0.040 |
Why?
|
| Cause of Death | 2 | 2015 | 441 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2021 | 289 | 0.040 |
Why?
|
| Prednisone | 1 | 2022 | 228 | 0.040 |
Why?
|
| Social Isolation | 1 | 2021 | 65 | 0.040 |
Why?
|
| Biomarkers | 1 | 2012 | 4175 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 712 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2002 | 165 | 0.040 |
Why?
|
| ROC Curve | 2 | 2014 | 589 | 0.040 |
Why?
|
| Psychometrics | 1 | 2004 | 734 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2021 | 151 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 99 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 1067 | 0.040 |
Why?
|
| Adult Children | 1 | 2020 | 26 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2002 | 299 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2002 | 246 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 515 | 0.040 |
Why?
|
| Social Stigma | 1 | 2021 | 147 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2002 | 284 | 0.040 |
Why?
|
| Health Literacy | 1 | 2021 | 176 | 0.040 |
Why?
|
| Home Care Services | 1 | 2002 | 260 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 2 | 2014 | 304 | 0.040 |
Why?
|
| Geographic Mapping | 1 | 2018 | 27 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2019 | 1022 | 0.040 |
Why?
|
| Research Design | 1 | 2004 | 1104 | 0.040 |
Why?
|
| Therapeutic Misconception | 1 | 2017 | 1 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2017 | 35 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2006 | 1122 | 0.030 |
Why?
|
| Censuses | 1 | 2017 | 35 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2012 | 328 | 0.030 |
Why?
|
| Veterans | 1 | 2009 | 1520 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2014 | 1815 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2003 | 3578 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 650 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2002 | 525 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 76 | 0.030 |
Why?
|
| State Government | 1 | 2014 | 45 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 118 | 0.030 |
Why?
|
| Albuminuria | 1 | 2015 | 185 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1240 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2014 | 170 | 0.030 |
Why?
|
| Terminally Ill | 1 | 2013 | 37 | 0.020 |
Why?
|
| Caregivers | 1 | 2020 | 940 | 0.020 |
Why?
|
| Trust | 1 | 2012 | 144 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 533 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 115 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 312 | 0.020 |
Why?
|
| Multilingualism | 1 | 2009 | 29 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2010 | 112 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2009 | 162 | 0.020 |
Why?
|
| Observation | 1 | 2008 | 56 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2008 | 28 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 1069 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 907 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2007 | 60 | 0.020 |
Why?
|
| Private Sector | 1 | 2007 | 51 | 0.020 |
Why?
|
| Personnel Turnover | 1 | 2007 | 38 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2009 | 244 | 0.020 |
Why?
|
| Domestic Violence | 1 | 2006 | 53 | 0.020 |
Why?
|
| Stroke | 1 | 2015 | 1158 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2007 | 255 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 82 | 0.010 |
Why?
|
| Herpesvirus 3, Human | 1 | 2008 | 336 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 802 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 1862 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2009 | 679 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2008 | 553 | 0.010 |
Why?
|
| Spironolactone | 1 | 2003 | 33 | 0.010 |
Why?
|
| Patient Care | 1 | 2004 | 117 | 0.010 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2003 | 55 | 0.010 |
Why?
|
| Poverty Areas | 1 | 2002 | 41 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2002 | 167 | 0.010 |
Why?
|
| Community Health Nursing | 1 | 2002 | 63 | 0.010 |
Why?
|
| Risk Adjustment | 1 | 2002 | 81 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 228 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 432 | 0.010 |
Why?
|
| Education, Medical | 1 | 2005 | 268 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2002 | 125 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 375 | 0.010 |
Why?
|
| Rural Population | 1 | 2004 | 605 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 523 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 3336 | 0.010 |
Why?
|